TrialPharmacogenetics and genomics2013

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.

Sarah Kraus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.